<DOC>
	<DOCNO>NCT02997696</DOCNO>
	<brief_summary>The purpose phase 2 , randomise , double-blind , placebo control , parallel group , multicentre study investigate efficacy , safety , tolerability pharmacokinetics compound ONO-4474 patient moderate severe pain due osteoarthritis knee follow 4 week oral administration ONO-4474 .</brief_summary>
	<brief_title>A Study Evaluate ONO-4474 Patients With Pain Due Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Symptomatic OA knee â‰¥3 month diagnose prior screen per American College Rheumatology clinical criterion . Radiographic evidence tibiofemoral OA index knee ( KellgrenLawrence grade 23 ) , confirm screening . Moderate severe index knee pain due OA require use analgesic medication . Willing discontinue use analgesic medication ( aside rescue medication ) study . Presence , history , 1. inflammatory arthritis ( e.g . gout , reactive arthritis , psoriatic arthritis , seronegative spondylarthropathy , septic arthritis , previous diagnosis pseudogout target joint proven crystal joint aspiration elevate CReactive Protein ( CRP ) time knee arthritis flare ) , 2 . RPOA , osteonecrosis , osteoporotic fracture painful joint disease OA , 3 . Secondary cause OA ; rheumatologic musculoskeletal condition ( e.g. , rheumatoid arthritis , fibromyalgia , septic arthritis , congenital abnormality ) . Orthopaedic surgery low extremity major surgery within previous 6 month prior Visit 1 plan surgical intervention study . Symptomatic hip OA . A history partial complete joint replacement surgery index knee time anticipate knee surgery study period . Significant knee injury knee surgery ( include arthroscopy ) index knee within 6 month prior screen . Uncontrolled diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>